ASTH — Astrana Health Inc. stock price and chart

ASTH

$38.58+4.55%

as of close, Oct 20, 2026

☾ AH $38.58 +4.55%

Astrana Health Inc.Stock · HealthcareRussell 2000 · 0.07% of IWMNasdaq Composite · 0.007% of ONEQRussell 3000 · 0.003% of IWVUS Stock Market · 0.003% of VTI

PeersENSGDVASPYQQQNVDAAAPL

Share this page

Technical analysis2

Overlay lines0

Addendum charts0

VolumeEEEEEEEEEEE

20162019202120242026

10.020.030.040.050.060.070.080.090.0100.0110.005.0M10.0M$38.58

2026-10-20

Price$38.58

MA20$39.27

MA50$31.79

Vol1.1M

What would $1,000 invested in ASTH be worth today? →

ASTH returns: By year · By month · By week · Trailing

Key stats#

Price data

Price: $38.58
YTD price return: +55.50%
YTD total return: +55.50%
Next earnings: Nov 5, 2026 · After close
Market cap: 1.9B2016-12 44.7M2026-10 1.9B+4198.5% over the window
Enterprise value: 2.5B
Shares outstanding: 49.8M2016-06 5.7M2026-06 49.8M+766.5% over the window
52W low: $18.08
52W high: $51.60
From 52W high: -25.23%
From 52W low: +113.38%
52W range: 61%

Volume

Rel volume: 0.64×
30D volume: 393.4K
30D $ vol: 14.2M

Fundamentals

Sales (ttm): 3.8B2016-06 46.2M2026-06 3.8B+8217.8% over the window
Sales/share: $77.232016-06 $8.042026-06 $77.23+860.0% over the window
EPS (ttm): $0.822016-12 $0.412026-06 $0.82+99.9% over the window
FCF (ttm): 94.4M2016-06 -4M2026-06 94.4M-2457.8% over the window
FCF/share: $1.902016-06 -$0.702026-06 $1.90-372.1% over the window
Book value/share: $16.682016-06 -$0.382026-06 $16.68-4445.6% over the window
Net margin: 1.05%2016-06 -17.7%2026-06 1.1%-106.0% over the window
ROE: 4.88%2016-12 13.1%2026-06 4.9%-62.8% over the window
ROA: 1.78%2016-06 -47.2%2026-06 1.8%-103.8% over the window
Debt / equity: 1.06×2018-12 0.002026-06 1.06
Current ratio: 1.232016-06 1.642026-06 1.23-24.8% over the window

Growth (CAGR, ttm) · 10Y

Sales: +58.96%2025-06-30 → 2026-06-302.4B → 3.8B (+58.9% total)+43.64%2023-06-30 → 2026-06-301.3B → 3.8B (+196.5% total)+40.25%2021-06-30 → 2026-06-30708.6M → 3.8B (+442.5% total)+55.61%2016-06-30 → 2026-06-3046.2M → 3.8B (+8217.8% total)
Net income: +60.58%2025-06-30 → 2026-06-3025.3M → 40.5M (+60.5% total)-3.95%2023-06-30 → 2026-06-3045.8M → 40.5M (-11.4% total)-3.72%2021-06-30 → 2026-06-3049M → 40.5M (-17.3% total)n/a
FCF: -22.17%2025-06-30 → 2026-06-30121.2M → 94.4M (-22.2% total)+15.57%2023-06-30 → 2026-06-3061.1M → 94.4M (+54.4% total)+10.69%2021-06-30 → 2026-06-3056.8M → 94.4M (+66.2% total)n/a
Shares: +0.62%2025-06-30 → 2026-06-3049.5M → 49.8M (+0.6% total)+2.26%2023-06-30 → 2026-06-3046.6M → 49.8M (+6.9% total)+2.38%2021-06-30 → 2026-06-3044.2M → 49.8M (+12.5% total)+24.10%2016-06-30 → 2026-06-305.7M → 49.8M (+766.5% total)

Per-share growth (CAGR, ttm) · 10Y

EPS: +57.91%2025-06-30 → 2026-06-30$0.52 → $0.82 (+57.9% total)-5.78%2023-06-30 → 2026-06-30$0.98 → $0.82 (-16.4% total)-7.49%2021-06-30 → 2026-06-30$1.21 → $0.82 (-32.3% total)+7.57%2016-12-31 → 2026-06-30$0.41 → $0.82 (+99.9% total)
Sales/share: +57.98%2025-06-30 → 2026-06-30$48.90 → $77.23 (+57.9% total)+40.47%2023-06-30 → 2026-06-30$27.85 → $77.23 (+177.3% total)+36.98%2021-06-30 → 2026-06-30$16.01 → $77.23 (+382.2% total)+25.38%2016-06-30 → 2026-06-30$8.04 → $77.23 (+860.0% total)
FCF/share: -22.65%2025-06-30 → 2026-06-30$2.45 → $1.90 (-22.6% total)+13.02%2023-06-30 → 2026-06-30$1.31 → $1.90 (+44.4% total)+8.11%2021-06-30 → 2026-06-30$1.28 → $1.90 (+47.7% total)n/a
Book value/share: +7.80%2025-06-30 → 2026-06-30$15.47 → $16.68 (+7.8% total)+11.11%2023-06-30 → 2026-06-30$12.16 → $16.68 (+37.2% total)+13.07%2021-06-30 → 2026-06-30$9.03 → $16.68 (+84.8% total)n/a
Dividend/share: -77.79%2025-06-30 → 2026-06-30$0.15 → $0.03 (-77.8% total)-6.19%2023-06-30 → 2026-06-30$0.04 → $0.03 (-17.5% total)-45.58%2020-12-31 → 2026-06-30$0.94 → $0.03 (-96.5% total)-40.34%2016-12-31 → 2026-06-30$4.48 → $0.03 (-99.3% total)
Price: +16.96%2025-10-20 → 2026-10-20$32.99 → $38.58 (+16.9% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.+7.00%2023-10-20 → 2026-10-20$31.49 → $38.58 (+22.5% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.-11.14%2021-10-20 → 2026-10-20$69.63 → $38.58 (-44.6% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.+26.25%2016-10-19 → 2026-10-20$3.75 → $38.58 (+928.8% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.
Total return: +16.96%2025-10-20 → 2026-10-20$32.99 → $38.58 (+16.9% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.+7.00%2023-10-20 → 2026-10-20$31.49 → $38.58 (+22.5% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.-11.14%2021-10-20 → 2026-10-20$69.63 → $38.58 (-44.6% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.+26.25%2016-10-19 → 2026-10-20$3.75 → $38.58 (+928.8% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.

Fundamentals end at the last reported quarter; price and total return end at the latest close.

Valuation

P/E (ttm)Price ÷ TTM diluted EPS. Net income carries everything below the operating line, including one-off gains. Negative when the trailing year lost money.: 47.1×2016-12 -4.962026-10 47.36-1054.5% over the window
P/OI (ttm)Price ÷ TTM operating income. Excludes the below-the-line items that make P/E jump — mark-to-market gains, settlements, tax true-ups.: 19.1×2016-12 -4.902026-10 19.12-490.5% over the window
Fwd P/E: 10.6×
P/S (ttm)Market cap ÷ TTM revenue.: 0.5×2016-12 0.902026-10 0.50-44.7% over the window
P/B (mrq)Market cap ÷ stockholders' equity at the most recent quarter end.: 2.3×2016-12 -13.632026-10 2.31-117.0% over the window
P/FCF (ttm)Market cap ÷ TTM free cash flow (operating cash flow − capex).: 20.3×2016-12 -11.162026-10 20.35-282.3% over the window
EV/EBITDA (fy): 15.4×
EV/Sales (ttm): 0.7×
FCF yield (ttm)TTM free cash flow ÷ market cap — the inverse of P/FCF.: 4.91%2016-12 41.6%2026-06 4.1%-90.2% over the window
Buyback yield (realized, 1y)1 − shares_at(2025-12-31) ÷ shares_at(2024-12-31) = 1 − 55.6M ÷ 56.3M. Point-in-time share counts from the company's own SEC filings (the same count at both ends), published only when the cash flow statement shows repurchases inside that window. A falling price can't inflate it; negative means net dilution.: 1.15%
Shareholder yield (realized, 1y)Buyback leg + dividend leg: shares retired over the year (1.15%) + dividends paid over that year ($1.9M) ÷ market_cap_at(2024-12-31) ($1.8B). Both legs are measured against the start of the window, so a payout can't shrink its own denominator.: 1.26%
Buyback yield (cash, ttm)Buybacks net of issuance over the trailing twelve months ($17.8M) ÷ today's market cap ($1.9B). Dollars SPENT over what the company is worth NOW — a stock that fell after buying reads high.: 0.93%2016-09 -0.4%2026-06 0.8%-272.1% over the window
Shareholder yield (cash, ttm)(TTM buybacks net of issuance $17.8M + TTM dividends $1.9M) ÷ today's market cap ($1.9B). Same caveat as the cash buyback yield.: 1.02%2016-09 -0.4%2026-06 0.9%-290.0% over the window

Vs own 10Y history

P/E: 64th
P/OI: 62nd
P/S: 13th
P/B: 18th
P/FCF: 31st

Bar = where today’s multiple sits in ASTH’s own 10-year range:near a decade-low (cheap)→near a decade-high (rich).

Performance · price return · as of 2026-10-20#

+4.55%

+1.87%

+12.28%

-13.40%

YTD

+55.50%

+16.94%

-44.59%

Financial statements

Open full ASTH financials →

Loading financial statements…

Ticker	Name	1M	1D
LLY	Eli Lilly and Company	+11.34%	+3.49%
JNJ	Johnson & Johnson	-3.94%	+2.19%
ABBV	AbbVie Inc.	+9.52%	+2.26%
UNH	UnitedHealth Group Incorporated Common Stock (DE)	+11.24%	+3.04%
MRK	Merck & Co. Inc.	+0.97%	+3.25%
NVS	Novartis AG	+9.45%	+2.29%
TMO	Thermo Fisher Scientific Inc.	+5.51%	+1.18%
AMGN	Amgen Inc.	+13.82%	+3.29%

ASTH — Astrana Health Inc. price, chart and key statistics